Huons Group Participates in Dubai Derma, Targets Middle East Aesthetic Market

Huons Group Operates Integrated Booth

Huons Group attended a dermatology and cosmetic exhibition held in Dubai, United Arab Emirates, where it showcased its portfolio of aesthetic products and took steps to expand its global influence.

On September 11, Huons Group announced that its subsidiaries—Humedics, Huons Meditech, and Huons Biopharma—participated in the international dermatology and cosmetic medicine conference "Dubai Derma 2026," held from the 8th to the 10th (local time) at the Dubai World Trade Center in the United Arab Emirates.

Huons Group's Humedix, Huons Meditech, and Huons Biopharma participated in the international dermatology and aesthetic medicine conference "Dubai Derma 2026," held from the 8th to the 10th (local time) at the Dubai World Trade Center in the United Arab Emirates. Huons

Dubai Derma is a major global academic and exhibition event in the dermatology and aesthetics fields, covering the Middle East, North Africa (MENA) region, and the Indian subcontinent market.

Huons Group set up an integrated booth to introduce its key products. The company also sought business opportunities in the Middle Eastern market by engaging with local medical professionals, distribution partners, and global stakeholders. Humedics showcased the filler brand "elravie," while Huons Meditech presented Dermashine Pro and its new product Dermashine DUO RF. Huons Biopharma promoted the botulinum toxin "Hutox" and related technologies.

A Huons Group representative stated, "Moving forward, we will continue to strengthen partnerships in the Middle East, expand our product portfolio in the region, and further establish our business foundation."

This content was produced with the assistance of AI translation services.